ESR1 and invasive ductal breast carcinoma: In January 2012, breast biopsy diagnosed an infiltrating ductal carcinoma of the breast, grade 3, estrogen receptor (ER)-positive (90%), progesterone receptor (PR)-positive (36%), HER2-positive (3+ by IHC), and MIB-1 36%.